Who owns Kaopectate?
Kaopectate is owned by Genomma Lab (Mexico, BMV: LAB), which has owned the brand since 2013.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV), Genomma Lab Internacional, S.A.B. de C.V. Last checked .
Key facts
- Current owner
- Genomma Lab Internacional, S.A.B. de C.V. reported
- Owned since
- Owner HQ
- 🇲🇽 Mexico, Mexico City
- Origin
- 🇺🇸 United States
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Parent ticker
- BMV: LAB
- Last verified
- · 1 sources
About Kaopectate
Kaopectate is an anti-diarrhoeal suspension that Genomma Lab acquired in 2013 as part of a package of brands bought from Johnson & Johnson with distribution across several Latin American countries. The same package brought it Agarol, Masse, Triatop, Emplastro Sabiá, Bebederm, Carlo Erba and Dulcoryl. The brand is often still assumed to be a Johnson & Johnson product in the markets Genomma took over.
Ownership timeline of Kaopectate
- 2013 – present Genomma Lab [1] reported
Where Kaopectate sits in Genomma Lab
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Genomma Lab ownership tree →
See the full Genomma Lab brand portfolio (13) →
Other brands owned by Genomma Lab
Genomma Lab controls 13 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
Other brands in digestive health, and who owns them
The 25 brands in digestive health on Brandtree belong to 18 owners. The largest is Bayer, with 2; Genomma Lab has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Epocler | Hypera | 🇧🇷 Brazil |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| First Response | Church & Dwight | 🇺🇸 United States |
About the owner: Genomma Lab
Genomma Lab is a publicly listed company headquartered in Mexico City, Mexico, founded in 1996. Brandtree records 13 brands under its control, and it is listed as BMV: LAB.
Genomma Lab Internacional is a Mexican over-the-counter medicine and personal care company that began in 1996 as a direct-response advertiser making its own television infomercials, moved into developing products of its own from 1997, and floated on the Mexican stock exchange as LAB on 18 June 2008. It sells more than 50 active brands in Mexico and eighteen countries beyond it, and puts its share of the Mexican over-the-counter market at 5.9 per cent and of the personal care categories it competes in at 5.0 per cent. Much of the portfolio was bought rather than invented.
🇺🇸 Kaopectate and other American brands
Brandtree records a controlling owner for 2,570 brands that began in the United States. 501 of them (19%) are now controlled by a company headquartered in another country, Kaopectate among them.
- Advil — Haleon 🇬🇧
- Alka-Seltzer — Bayer 🇩🇪
- Band-Aid — Kenvue 🇺🇸
- Breathe Right — Prestige Consumer Healthcare 🇺🇸
- Doan's — Dr. Reddy's 🇮🇳
- First Response — Church & Dwight 🇺🇸
Frequently asked questions
Who is the parent company of Kaopectate?
The parent company of Kaopectate is Genomma Lab, a publicly listed company headquartered in Mexico.
Is Kaopectate owned by Johnson & Johnson?
No. Kaopectate is owned by Genomma Lab, not Johnson & Johnson.
Is Kaopectate American or Mexican?
Kaopectate originated in the United States, but it is owned today by Genomma Lab, which is headquartered in Mexico. So Kaopectate is an American-origin brand under Mexican ownership.
Since when has Genomma Lab owned Kaopectate?
Genomma Lab has owned Kaopectate since 2013.
Is Kaopectate still owned by Genomma Lab?
Yes. As of 23 September 2026, Kaopectate is still owned by Genomma Lab. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.